CUV Presentation to international porphyria patient group 08/02/16 download Created with Sketch. 1.74MB Share CUV Appendix 4C - quarterly 28/01/16 PRICE SENSITIVE download Created with Sketch. 172.15KB Share CUV Change in substantial holding 25/01/16 download Created with Sketch. 1.25MB Share CUV CEO Brief 20/01/16 download Created with Sketch. 270.13KB Share CUV Change in substantial holding 18/01/16 download Created with Sketch. 246.56KB Share CUV Update on North American vitiligo program for SCENESSE 03/12/15 PRICE SENSITIVE download Created with Sketch. 132.79KB Share CUV Positive preliminary results in Singaporean vitiligo study 03/12/15 PRICE SENSITIVE download Created with Sketch. 133.07KB Share CUV Results of Meeting 24/11/15 download Created with Sketch. 102KB Share CUV CEO's AGM Presentation 24/11/15 download Created with Sketch. 2.98MB Share CUV Chairman's Address to Shareholders 24/11/15 download Created with Sketch. 102.79KB Share CUV Change in substantial holding 04/11/15 download Created with Sketch. 3.33MB Share CUV Appendix 4C - quarterly 30/10/15 PRICE SENSITIVE download Created with Sketch. 137.79KB Share CUV Appendix 4G and Corporate Governance Statement 23/10/15 download Created with Sketch. 679.3KB Share CUV Annual Report to shareholders 23/10/15 download Created with Sketch. 3.46MB Share CUV Notice of Annual General Meeting/Proxy Form 23/10/15 download Created with Sketch. 651.05KB Share CUV Change in substantial holding 07/10/15 download Created with Sketch. 559.76KB Share CUV AGM Date 06/10/15 download Created with Sketch. 254.13KB Share CUV FDA Meeting 05/10/15 download Created with Sketch. 268.27KB Share CUV Becoming a substantial holder 23/09/15 download Created with Sketch. 773.09KB Share CUV SCENESSE released for European Distribution 21/09/15 PRICE SENSITIVE download Created with Sketch. 284.3KB Share CUV Preliminary Final Report 31/08/15 PRICE SENSITIVE download Created with Sketch. 1.03MB Share CUV FDA grants Clinuvel a Type C Meeting 27/08/15 PRICE SENSITIVE download Created with Sketch. 143.62KB Share CUV Appendix 4C - quarterly 31/07/15 PRICE SENSITIVE download Created with Sketch. 138.06KB Share CUV Ceasing to be a substantial holder 30/07/15 download Created with Sketch. 159.82KB Share CUV Clinuvel Newsletter - July 2015 15/07/15 download Created with Sketch. 175.38KB Share CUV NEJM publishes Phase III SCENESSE studies 02/07/15 PRICE SENSITIVE download Created with Sketch. 134.46KB Share CUV SCENESSE Commercialisation Update 05/06/15 PRICE SENSITIVE download Created with Sketch. 282.58KB Share CUV Clinuvel announces innovative melanocortin 05/05/15 PRICE SENSITIVE download Created with Sketch. 131.32KB Share CUV Appendix 4C - quarterly 27/04/15 PRICE SENSITIVE download Created with Sketch. 137.52KB Share CUV Clinuvel Relocates Melbourne Office 31/03/15 download Created with Sketch. 205.87KB Share CUV Appendix 3B 20/03/15 download Created with Sketch. 547.71KB Share CUV SCENESSE data presented at US dermatology conference 20/03/15 download Created with Sketch. 119.32KB Share CUV SCENESSE breakthrough featured in peer-reviewed editorial 20/03/15 download Created with Sketch. 115.97KB Share CUV Clinuvel Newsletter - March 2015 12/03/15 download Created with Sketch. 1.09MB Share MPL S&P DJ Indices Announces March Quarterly Review 06/03/15 PRICE SENSITIVE download Created with Sketch. 100.19KB Share CUV Appendix 3B 02/03/15 download Created with Sketch. 550KB Share CUV Half Yearly Report and Accounts 25/02/15 PRICE SENSITIVE download Created with Sketch. 265.55KB Share CUV Appendix 4C - quarterly 30/01/15 PRICE SENSITIVE download Created with Sketch. 138.2KB Share CUV Change of Director's Interest Notice 23/01/15 download Created with Sketch. 728.77KB Share CUV Appendix 3B 23/01/15 download Created with Sketch. 549.52KB Share CUV Initial Director's Interest Notice 21/01/15 download Created with Sketch. 342.33KB Share CUV Clinuvel appoints new Non-Executive Director 21/01/15 download Created with Sketch. 210.85KB Share CUV European Commission approves SCENESSE 23/12/14 PRICE SENSITIVE download Created with Sketch. 275.65KB Share CUV Change of Director's Interest Notice x 3 23/12/14 download Created with Sketch. 681.88KB Share CUV Appendix 3B 23/12/14 download Created with Sketch. 544.6KB Share CUV Long term use of SCENESSE in EPP published in BJD 15/12/14 download Created with Sketch. 121.02KB Share CUV Change in substantial holding 05/12/14 download Created with Sketch. 278.54KB Share CUV Change of Director's Interest Notice * 4 04/12/14 download Created with Sketch. 857.15KB Share CUV Appendix 3B 04/12/14 download Created with Sketch. 548.6KB Share CUV Investor Update Presentation 04/12/14 download Created with Sketch. 1.13MB Share CUV Results of Meeting 28/11/14 download Created with Sketch. 101.25KB Share CUV Chairman's Address 28/11/14 download Created with Sketch. 87.82KB Share CUV CEO's AGM presentation 28/11/14 download Created with Sketch. 4.08MB Share CUV Letter to Shareholders 05/11/14 download Created with Sketch. 256.29KB Share CUV Letter to Shareholders 03/11/14 download Created with Sketch. 299.92KB Share CUV Appendix 4C - quarterly 29/10/14 PRICE SENSITIVE download Created with Sketch. 150.11KB Share CUV Clinuvel to host investor teleconference 28/10/14 download Created with Sketch. 83.46KB Share CUV Annual Report to shareholders 27/10/14 download Created with Sketch. 1.18MB Share CUV Notice of Annual General Meeting/Proxy Form 27/10/14 download Created with Sketch. 665.02KB Share CUV SCENESSE attains breakthrough European Market Authorisation 27/10/14 PRICE SENSITIVE download Created with Sketch. 131.83KB Share CUV Trading Halt 24/10/14 PRICE SENSITIVE download Created with Sketch. 240.88KB Share CUV AGM Date 10/10/14 download Created with Sketch. 216.29KB Share CUV Lapse and Forfeit of Unlisted Conditional Performance Rights 10/10/14 download Created with Sketch. 187.82KB Share CUV SCENESSE data to be presented at EADV conference 08/10/14 download Created with Sketch. 92.14KB Share CUV EMA Oral Explanation Update 26/09/14 PRICE SENSITIVE download Created with Sketch. 90.07KB Share CUV Clinuvel invited to present at EMA's CHMP plenary session 22/09/14 download Created with Sketch. 299.84KB Share CUV Clinuvel enters a joint venture with Biotech Lab Singapore 19/09/14 PRICE SENSITIVE download Created with Sketch. 281.14KB Share CUV JAMA Dermatology publishes SCENESSE vitiligo study results 19/09/14 PRICE SENSITIVE download Created with Sketch. 152KB Share CUV Response to ASX Price Query 16/09/14 PRICE SENSITIVE download Created with Sketch. 536.23KB Share CUV Change in substantial holding 12/09/14 download Created with Sketch. 890.53KB Share CUV Change in substantial holding 11/09/14 download Created with Sketch. 1.12MB Share CUV Preliminary Final Report 25/08/14 PRICE SENSITIVE download Created with Sketch. 2.05MB Share CUV Chairman's Update 18/08/14 download Created with Sketch. 292.16KB Share CUV Clinuvel declines unsolicited proposal from Retrophin 08/08/14 PRICE SENSITIVE download Created with Sketch. 118.72KB Share CUV Appendix 3B 07/08/14 download Created with Sketch. 549.84KB Share CUV Appendix 4C - quarterly 31/07/14 PRICE SENSITIVE download Created with Sketch. 33.46KB Share CUV Final Director's Interest Notice 31/07/14 download Created with Sketch. 109.47KB Share CUV Becoming a substantial holder 30/07/14 download Created with Sketch. 265.21KB Share CUV Becoming a substantial holder 30/07/14 download Created with Sketch. 257.08KB Share CUV Proposal to acquire all the outstanding shares in Clinuvel P 28/07/14 download Created with Sketch. 999.46KB Share CUV Mr Jack Wood 28/07/14 download Created with Sketch. 85.15KB Share CUV Clinuvel receives an unsolicited bid for the Company 28/07/14 PRICE SENSITIVE download Created with Sketch. 89.73KB Share CUV Clinuvel Newsletter July 2014 16/07/14 download Created with Sketch. 328.13KB Share CUV US orphan-drug designation in Hailey-Hailey Disease 22/05/14 PRICE SENSITIVE download Created with Sketch. 313.99KB Share CUV s.708A Notice 20/05/14 download Created with Sketch. 34.01KB Share CUV Becoming a substantial holder 20/05/14 download Created with Sketch. 52.63KB Share CUV Appendix 3B 20/05/14 download Created with Sketch. 512.46KB Share CUV Euro orphan designation in Hailey-Hailey Disease - SCENESSE 19/05/14 download Created with Sketch. 118.76KB Share CUV Management Update 19/05/14 PRICE SENSITIVE download Created with Sketch. 415.41KB Share CUV Clinuvel placement 14/05/14 PRICE SENSITIVE download Created with Sketch. 427.27KB Share CUV Trading Halt Request 12/05/14 download Created with Sketch. 155.48KB Share CUV Trading Halt 12/05/14 PRICE SENSITIVE download Created with Sketch. 77.85KB Share CUV Phase II vitiligo study commences in Singapore 06/05/14 PRICE SENSITIVE download Created with Sketch. 368.83KB Share CUV Appendix 4C - quarterly 17/04/14 PRICE SENSITIVE download Created with Sketch. 150.32KB Share CUV Lapse and Forfeit of Unlisted Conditional Performance Rights 14/04/14 download Created with Sketch. 189.38KB Share CUV Clinuvel Newsletter April 2014 14/04/14 download Created with Sketch. 1.72MB Share CUV SCENESSE data to feature at American Academy of Dermatology 20/03/14 download Created with Sketch. 129.81KB Share CUV Half Yearly Report and Accounts 26/02/14 PRICE SENSITIVE download Created with Sketch. 320.92KB Share CUV Phase II study starts in skin disorder Hailey-Hailey Disease 10/02/14 PRICE SENSITIVE download Created with Sketch. 301.25KB Share CUV Clinuvel Newsletter 04/02/14 download Created with Sketch. 391.27KB Share